TXNIP and breast carcinoma: This finding was in contrast with that of a study by Woolston et al., which included 98 patients with locally advanced breast cancer; the authors found that high expression levels of TrxR (p = 0.021) and TxNIP (p = 0.021) were significantly associated with improved distant metastasis-free survival [27].